Evaluation of the effect of hetastarch and lactated Ringer's solution on plasma colloid osmotic pressure in healthy llamas

Katelyn R. Carney Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331.

Search for other papers by Katelyn R. Carney in
Current site
Google Scholar
PubMed
Close
 DVM
,
Erica C. McKenzie Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331.

Search for other papers by Erica C. McKenzie in
Current site
Google Scholar
PubMed
Close
 BVMS, PhD, DACVIM
,
Craig A. Mosley Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331.

Search for other papers by Craig A. Mosley in
Current site
Google Scholar
PubMed
Close
 DVM, MS, DACVA
, and
Mark E. Payton Department of Statistics, College of Arts and Sciences, Oklahoma State University, Stillwater, OK 74078.

Search for other papers by Mark E. Payton in
Current site
Google Scholar
PubMed
Close
 PhD

Abstract

Objective—To compare the effects of hetastarch and lactated Ringer's solution (LRS) on plasma colloid osmotic pressure (pCOP) and other hematologic variables in healthy llamas.

Design—Prospective crossover study.

Animals—6 healthy female llamas.

Procedures—Llamas were administered LRS (45 mL/kg [20.5 mL/lb]) and, after a 3-day washout period, hetastarch (15 mL/kg [6.8 mL/lb]) during 60-minute IV infusions. Serum total protein, serum albumin, and hemoglobin concentrations and Hct were measured before each infusion (baseline), immediately after each infusion was completed (0 hours), and at 2, 4, 8, and 12 hours. The pCOP was measured at baseline and at 0, 2, 4, 8, 12, 24, 36, and 48 hours after each infusion was completed; additional measurements of pCOP were obtained 72 and 96 hours after hetastarch infusion.

Results—Hetastarch administration significantly increased mean ± SEM pCOP from 23.5 ± 0.3 mm Hg (baseline) to a peak of 28.4 ± 0.6 mm Hg (12 hours); significant increases in pCOP persisted at 96 hours after hetastarch administration. Administration of LRS significantly decreased albumin and total protein concentrations; in addition, mean ± SEM pCOP decreased from 24.1 ± 0.4 mm Hg (baseline) to 18.0 ± 0.3 mm Hg (0 hours). Hetastarch administration caused more pronounced decreases in Hct (0 hours) and concentrations of hemoglobin (0 hours), albumin (all time points), and total protein (all time points) than did LRS administration.

Conclusions and Clinical Relevance—Hetastarch administration increased pCOP in healthy llamas for 96 hours with no clinically important complications.

Abstract

Objective—To compare the effects of hetastarch and lactated Ringer's solution (LRS) on plasma colloid osmotic pressure (pCOP) and other hematologic variables in healthy llamas.

Design—Prospective crossover study.

Animals—6 healthy female llamas.

Procedures—Llamas were administered LRS (45 mL/kg [20.5 mL/lb]) and, after a 3-day washout period, hetastarch (15 mL/kg [6.8 mL/lb]) during 60-minute IV infusions. Serum total protein, serum albumin, and hemoglobin concentrations and Hct were measured before each infusion (baseline), immediately after each infusion was completed (0 hours), and at 2, 4, 8, and 12 hours. The pCOP was measured at baseline and at 0, 2, 4, 8, 12, 24, 36, and 48 hours after each infusion was completed; additional measurements of pCOP were obtained 72 and 96 hours after hetastarch infusion.

Results—Hetastarch administration significantly increased mean ± SEM pCOP from 23.5 ± 0.3 mm Hg (baseline) to a peak of 28.4 ± 0.6 mm Hg (12 hours); significant increases in pCOP persisted at 96 hours after hetastarch administration. Administration of LRS significantly decreased albumin and total protein concentrations; in addition, mean ± SEM pCOP decreased from 24.1 ± 0.4 mm Hg (baseline) to 18.0 ± 0.3 mm Hg (0 hours). Hetastarch administration caused more pronounced decreases in Hct (0 hours) and concentrations of hemoglobin (0 hours), albumin (all time points), and total protein (all time points) than did LRS administration.

Conclusions and Clinical Relevance—Hetastarch administration increased pCOP in healthy llamas for 96 hours with no clinically important complications.

Contributor Notes

Dr. Mosley's present address is Canada West Veterinary Specialists & Critical Care Hospital, 1988 Kootenay St, Vancouver, BC V5M 4Y3, Canada.

Dr Carney's present address is Banfield, The Pet Hospital, 316 NE 78th St, Vancouver, WA 98665.

Supported by the Willamette Valley Llama Foundation (now the North West Camelid Foundation).

Address correspondence to Dr. McKenzie (erica.mckenzie@oregonstate.edu).
  • 1.

    Kirby R, Rudloff E. The critical need for colloids: maintaining fluid balance. Compend Contin Educ Pract Vet 1997; 19:705717.

  • 2.

    McFarlane D. Hetastarch: a synthetic colloid with potential in equine patients. Compend Contin Educ Pract Vet 1999; 21:867877.

  • 3.

    Wills BA, Nguyen MD, Ha TL, et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 2005; 353:877889.

  • 4.

    Wellman ML, DiBartola SP, Kohn CW. Applied physiology of body fluids in dogs and cats. In: DiBartola SP, ed. Fluid, electrolyte and acid-base disorders in small animal practice. 3rd ed. St Louis: Saunders Elsevier, 2006;325.

    • Search Google Scholar
    • Export Citation
  • 5.

    Ganong WE The general & cellular basis of medical physiology In: Ganong WF, ed. Review of medical physiology. 22nd ed. New York: McGraw-Hill, 2005;150.

    • Search Google Scholar
    • Export Citation
  • 6.

    King LG. Colloid fluid therapy and colloid osmotic pressure, in Proceedings. 12th Annu Meet Vet Med Forum 1994;404–407.

  • 7.

    Brückner UB, Albrecht M, Frey L, et al. Fluid resuscitation in canine traumatic-hemorrhagic shock: long-term comparison of hydroxyethyl starch vs. Ringer's lactate. Prog Clin Biol Res 1987; 236B:197204.

    • Search Google Scholar
    • Export Citation
  • 8.

    Hein LG, Albrecht M, Dworschak M, et al. Long-term observation following traumatic-hemorrhagic shock in the dog: a comparison of crystalloidal vs. colloidal fluids. Circ Shock 1988; 26:353364.

    • Search Google Scholar
    • Export Citation
  • 9.

    Yacobi A, Gibson TP, McEntegart CM, et al. Pharmacokinetics of high molecular weight hydroxyethyl starch in dogs. Res Commun Chem Pathol Pharmacol 1982; 36:199204.

    • Search Google Scholar
    • Export Citation
  • 10.

    Yacobi A, Stoll RG, Sum CY, et al. Pharmacokinetics of hydroxyethyl starch in normal subjects. J Clin Pharm 1982; 22:206212.

  • 11.

    Griffel MI, Kaufman BS. Pharmacology of colloids and crystalloids. Crit Care Clin 1992; 8:235253.

  • 12.

    Cebra CK, Mattson DE, Baker RJ, et al. Potential pathogens in feces from unweaned llamas and alpacas with diarrhea. J Am Vet Med Assoc 2003; 223:18061808.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Cebra CK, Valentine BA, Schlipf JW, et al. Eimeria macusaniensis infection in 15 llamas and 34 alpacas. J Am Vet Med Assoc 2007; 230:94100.

  • 14.

    Waitt LH, Cebra CK, Firshman AM, et al. Cryptosporidiosis in 20 alpaca crias. J Am Vet Med Assoc 2008; 233:294298.

  • 15.

    Boscan P, Watson Z, Steffey EP. Plasma colloid osmotic pressure and total protein trends in horses during anesthesia. Vet Anaesth Analg 2007; 34:275283.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Wright BD, Hopkins A. Changes in colloid osmotic pressure as a function of anesthesia and surgery in the presence and absence of isotonic fluid administration in dogs. Vet Anaesth Analg 2008; 35:282288.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17.

    Animal Medicinal Drug Use Clarification Act (AMDUCA) of 1994. Available at: www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/AnimalMedicinalDrugUseClarificationActAMDUCAof1994/default.htm. Accessed Oct 19, 2009.

    • Search Google Scholar
    • Export Citation
  • 18.

    Marx G, Cobas Meyer M, Schuerholz T, et al. Hydroxyethyl starch and modified fluid gelatin maintain plasma volume in a porcine model of septic shock with capillary leakage. Intensive Care Med 2002; 28:629635.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Jones PA, Tomasic M, Gentry PA. Oncotic, hemodilutional, and hemostatic effects of isotonic saline and hydroxyethyl starch solutions in clinically normal ponies. Am J Vet Res 1997; 58:541548.

    • Search Google Scholar
    • Export Citation
  • 20.

    Smiley LE, Garvey MS. The use of hetastarch as adjunct therapy in 26 dogs with hypoalbuminemia: a phase 2 clinical trial. J Vet Intern Med 1994; 8:195202.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21.

    Wierenga JR, Jandrey KE, Haskins SC, et al. In vitro comparison of the effects of two forms of hydroxyethyl starch solutions on platelet function in dogs. Am J Vet Res 2007; 68:605609.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22.

    Smart L, Jandrey KE, et al. The effect of hetastarch (670/0.75) in vivo on platelet closure time in the dog. J Vet Emerg Crit Care (San Antonio) 2009; 19:444449.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23.

    Chan DL. Colloids: current recommendations. Vet Clin North Am Small Anim Pract 2008; 38:587593.

  • 24.

    Barron ME, Wilkes MM, Navickis RJ. A systematic review of the comparative safety of colloids. Arch Surg 2004; 139:552563.

Advertisement